vaccine venture capital

Latest Headlines

Latest Headlines

ImmusanT lands $20M for celiac vaccine work

ImmusanT has won a big round of venture capital for its work on a vaccine for celiac disease. Vatera Healthcare Partners is putting up $20 million to help support clinical development of Nexvax2. A

Hoopika lands $10M for vaccine platform

Austria-based Hoopika has landed $10 million to back development of its platform vaccine technology and fund early-stage trials of the company's lead drug. Sofinnova Partners led the round, with help

Gates steps in to vaccine VC with $10M investment

The Bill and Melinda Gates Foundation, long a staunch supporter of vaccines for children, is putting its money where its mouth is with a $10 million investment in Liquidia Technologies. Xconomy notes

Cancer vax developer Kite lands $15M

LA-based Kite Pharma, a fledgling biotech that has set out to develop new cancer vaccine therapies, has raised $15 million in Series A venture cash. The company will use the funding to support